Azzad Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,438
Closed -$1.45M 320
2022
Q3
$1.45M Sell
5,438
-9
-0.2% -$1.91K 0.15% 207
2022
Q2
$1.44M Buy
+5,447
New +$1.11M 0.14% 213
2021
Q2
Sell
-6,411
Closed -$1.79M 325
2021
Q1
$1.79M Buy
6,411
+216
+3% +$58.3K 0.3% 141
2020
Q4
$1.52M Sell
6,195
-40
-0.6% -$10.3K 0.28% 146
2020
Q3
$1.77M Buy
6,235
+997
+19% +$278K 0.37% 103
2020
Q2
$1.4M Buy
5,238
+2,402
+85% +$722K 0.33% 113
2020
Q1
$897K Sell
2,836
-5,179
-65% -$1.57M 0.26% 142
2019
Q4
$2.23M Buy
8,015
+42
+0.5% +$11.7K 0.26% 138
2019
Q3
$2.04M Buy
7,973
+5,258
+194% +$1.22M 0.25% 144
2019
Q2
$635K Buy
2,715
+1,117
+70% +$258K 0.17% 203
2019
Q1
$378K Sell
1,598
-22
-1% -$6.93K 0.11% 247
2018
Q4
$488K Sell
1,620
-118
-7% -$37.7K 0.16% 214
2018
Q3
$614K Sell
1,738
-17
-1% -$5.85K 0.16% 212
2018
Q2
$509K Buy
1,755
+35
+2% +$9.84K 0.15% 231
2018
Q1
$471K Buy
1,720
+47
+3% +$14.6K 0.14% 231
2017
Q4
$533K Buy
1,673
+79
+5% +$25.3K 0.17% 191
2017
Q3
$499K Buy
1,594
+94
+6% +$27.8K 0.17% 200
2017
Q2
$407K Buy
1,500
+132
+10% +$34.9K 0.15% 221
2017
Q1
$374K Buy
1,368
+127
+10% +$35.9K 0.14% 217
2016
Q4
$352K Buy
1,241
+44
+4% +$13K 0.15% 209
2016
Q3
$375K Sell
1,197
-19
-2% -$5.63K 0.15% 207
2016
Q2
$294K Buy
1,216
+420
+53% +$111K 0.13% 222
2016
Q1
$207K Buy
796
+116
+17% +$30.6K 0.09% 230
2015
Q4
$208K Buy
+680
New +$195K 0.1% 229

Other funds holding BIIB